- Supported exchanges /
- F /
- 3AC.F
Actinogen Medical Limited (3AC F) stock market data APIs
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials, that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Actinogen Medical Limited Financial Data Overview
| 0.0125 | |
| 0.0125 | |
| - | |
| 0.0125 | |
| 0.0125 | |
| 0.009-0.054 | |
| 43 361 K | |
| 2 945 M | |
| 9 932 K | |
| 1.735 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Actinogen Medical Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 9 932 K
- EBITDA -12 921 170
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Actinogen Medical Limited Earnings via APIs
- Latest Release 2024-10-29
- EPS/Forecast NaN
Get Actinogen Medical Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
